The end of parallel trade with patented pharmaceuticals?

This seminar paper analyzes the relationship between patent and competition law in the pharmaceutical sector, focusing on the implications of the Lelos Case and parallel trade. It discusses the ECJ's decision and its impact on the principle of exhaustion, while briefly addressing relevant market conditions and research costs.